TrialJAMA network open2023

Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.

Kevin W Garey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.